Christina X. Chamberlain




Ph.D., pharmaceutical economics and policy, and B.S., biomedical engineering, University of Southern California

Summary of Experience

Dr. Chamberlain specializes in health economics and outcomes research (HEOR). Her experience in this field includes application of statistical methods and strategic thinking to comparative-effectiveness and cost-effectiveness analyses for early-phase evaluation, as well as submission to health technology assessment (HTA) agencies, real-world outcomes research, burden-of-illness research, qualitative studies, and patient-reported outcome (PRO) and survey studies. Dr. Chamberlain has worked closely with pharmaceutical and biotechnology companies to support product launches and develop research strategies in a range of therapeutic areas, including oncology, rheumatology, hematology, cardiovascular disease, neurodegenerative diseases, and various rare diseases. Her research has been published in peer-reviewed journals and presented at international clinical and economic research conferences.